DIGITAL THERAPEUTICS MARKET

1
MarketsandMarkets Presents
Digital Therapeutics Market worth 457.9 Million
USD by 2021
http//www.marketsandmarkets.com/Market-Reports/di
gital-therapeutics-market-51646724.html
2
The report "Digital Therapeutics Market by
Application (Prevention (Prediabetes, Obesity),
Care (Diabetes, CVD, CNS, CRD, Smoking Cessation,
Musculoskeletal)), Sales Channel (B2C (Patient,
Caregiver), B2B (Provider, Payer, Employer,
Pharma)) - Global Forecast to 2021", The global
digital therapeutics market is expected to reach
USD 457.9 Million by 2021 from USD 110 Million in
2016, growing at a CAGR of 27.7 from 2016 to
2021. Browse 148 market data tables 536
figures  186 Pages And in-depth TOC on  Digital
Therapeutics Market Ask For The PDF Brochure
http//tinyurl.com/zog3yrz Digital therapeutics
refers to health or social care interventions
delivered through a smart device to support
healthy behaviors and provide therapeutic
effects. Digital therapies/programs are
cost-effective and have the potential to improve
patient engagement and bring a substantial change
in patients health. Owing to these advantages,
digital therapeutics is increasingly being
prescribed to help manage long-term conditions
such as diabetes, insomnia, and asthma.
http//www.marketsandmarkets.com/Market-Reports/di
gital-therapeutics-market-51646724.html
3
On the basis of application, the digital
therapeutics market is segmented into preventive
and treatment/care-based applications. On the
basis of sales channel, the digital therapeutics
market is segmented into B2C and B2B sales
channel. The B2B segment is estimated to command
the largest share in 2016 and register the
highest CAGR in the digital therapeutics market,
by sales channel. Factors such as growing
awareness among providers, payers, and employers
about the benefits of digital therapeutics and
the growing inclination of pharmaceutical
companies to integrate digital therapeutics with
their drug products are driving the growth of
this segment. Get The Sample Copy Of This
Report http//tinyurl.com/jdsrdrc Based on
geography, the global digital therapeutics market
is segmented into North America, Europe,
Asia-Pacific, and the Rest of the World (RoW).
North America is expected to account for the
largest share of the market by the end of 2016.
This large share can be attributed to various
factors, including growing incidence of chronic
diseases, government initiatives to support
technological advancements in the field of
digital therapeutics, and a growing influx of new
startup companies in the market.
http//www.marketsandmarkets.com/Market-Reports/di
gital-therapeutics-market-51646724.html
4
North America dominates the digital therapeutics
market, with the U.S. accounting for the major
share and highest CAGR. This can be attributed to
the growing incidence of chronic diseases,
government initiatives to support technological
advancements in digital therapeutics, gradually
improving reimbursement structure for digital
therapeutics solutions, and a growing influx of
new startup companies in the market as a result
of increasing investments in the digital
therapeutics field. For instance, in July 2014,
Proteus Digital Health (U.S.) secured an
investment of USD 172 million from a list of
institutional investors for the manufacturing and
development of its digital medicine products.
Furthermore, in January 2014, WellDoc, Inc.
(U.S.) received USD 20 million from the Merck
Global Health Innovation Fund (U.S.), which it
used to commercialize its products in the U.S.
Such investments are likely to spur the growth of
the market in North America in the coming
years. The prominent players in the digital
therapeutics market are Proteus Digital Health,
Inc. (U.S.), Omada Health Inc. (U.S.), WellDoc
Inc. (U.S.), Livongo Health (U.S.), Noom Inc.
(U.S.), Ginger.io Inc. (U.S.), Propeller Health
(U.S.), 2Morrow Inc. (U.S.), Canary Health Inc.
(U.S.), and Mango Health, Inc. (U.S.).
http//www.marketsandmarkets.com/Market-Reports/di
gital-therapeutics-market-51646724.html
5
About MarketsandMarkets MarketsandMarkets is
the largest market research firm worldwide in
terms of annually published premium market
research reports. Serving 1700 global fortune
enterprises with more than 1200 premium studies
in a year, MM is catering to multitude of
clients across 8 different industrial verticals.
We specialize in consulting assignments and
business research across high growth markets,
cutting edge technologies and newer applications.
Our 850 fulltime analyst and SMEs at
MarketsandMarkets are tracking global high growth
markets following the "Growth Engagement Model
GEM". MMs flagship competitive intelligence
and market research platform, "RT" connects over
200,000 markets and entire value chains for
deeper understanding of the unmet insights along
with market sizing and forecasts of niche
markets. The new included chapters on Methodology
and Benchmarking presented with high quality
analytical infographics in our reports gives
complete visibility of how the numbers have been
arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help
our clients grow by providing apt business
insight with our huge market intelligence
repository.
http//www.marketsandmarkets.com/Market-Reports/di
gital-therapeutics-market-51646724.html
6
Contact Us
Mr. Rohan MarketsandMarkets 701 Pike Street
Suite 2175, Seattle, WA 98101, United
StatesEmail sales_at_marketsandmarkets.com Markets
andMarkets Bloghttp//www.marketsandmarkets.comh
ttp//twitter.com/marketsmarkets http//www.linked
in.com/company/marketsandmarkets